Literature DB >> 3427442

Gonadal influences on spinal cord and brain monoamines in male rats.

E Battaner1, A Rodriguez del Castillo, M Guerra, M Mas.   

Abstract

Concentrations of norepinephrine (NE), dopamine (DA), 3,4-dihydroxy phenylacetic acid (DOPAC), serotonin (HT) and 5-hydroxyindoleacetic acid (HIAA) were measured by high-performance liquid chromatography-electrical detection (HPLC-ED) in homogenates of lumbosacral spinal cord, mediobasal hypothalamus and cerebral cortex of male rats. The effects of castration and testosterone propionate (TP) (20 micrograms/day X 2 days) were compared. Castrated animals had the highest levels of DA and DOPAC in the cerebral cortex and NE, HT and HIAA in the spinal cord, as well as decreased hypothalamic DOPAC. Testosterone treatment returned spinal cord monoamine concentrations to intact control levels. These findings point to the spinopetal monoaminergic pathways as sensitive targets for androgen action.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3427442     DOI: 10.1016/0006-8993(87)90528-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  Gonadectomy and hormone replacement affects in vivo basal extracellular dopamine levels in the prefrontal cortex but not motor cortex of adult male rats.

Authors:  T Aubele; M F Kritzer
Journal:  Cereb Cortex       Date:  2010-05-13       Impact factor: 5.357

2.  In vitro binding assays using (3)H nisoxetine and (3)H WIN 35,428 reveal selective effects of gonadectomy and hormone replacement in adult male rats on norepinephrine but not dopamine transporter sites in the cerebral cortex.

Authors:  B Meyers; M F Kritzer
Journal:  Neuroscience       Date:  2008-12-14       Impact factor: 3.590

3.  Perinatal gonadectomy exerts regionally selective, lateralized effects on the density of axons immunoreactive for tyrosine hydroxylase in the cerebral cortex of adult male rats.

Authors:  M F Kritzer
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.